FDA grants fast-track review for over-the-counter overdose drug ...Middle East

The Hill - News
FDA grants fast-track review for over-the-counter overdose drug
The Food and Drug Administration (FDA) is fast-tracking the review for a new opioid overdose reversal drug that would be available over the counter.  The nonprofit pharmaceutical company Harm Reduction Therapeutics on Monday said in a release the FDA had granted it priority review for a new drug application for RiVive, a naloxone nasal spray for emergency overdose treatment.   Naloxone is a drug administered to reverse the effects of a suspected opioid overdose. Under brand names like Narcan, naloxone is usually available without a prescription, but sold behind the counter. Harm Reduction Therapeutics co-founder and CEO Michael Hufford said the drug application’s progress indicat

Hence then, the article about fda grants fast track review for over the counter overdose drug was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA grants fast-track review for over-the-counter overdose drug )

Apple Storegoogle play

Last updated :

Also on site :